Summary
Eli Lilly & Co. (LLY) filed an 8-K report on December 21, 2004, detailing several key events that occurred around December 20, 2004. The most significant update for investors concerns the company's ongoing restructuring efforts, which have led to an upward revision of estimated charges. The total pretax charges are now expected to range between $400 million and $465 million, an increase from the previously estimated $320 million to $420 million. This revision is primarily driven by asset impairments related to a reconfiguration of the Prince William County, Virginia facility, along with updated estimates for other restructuring costs. Furthermore, the filing outlines the 2005 bonus targets for employees, which will be based 75% on earnings-per-share growth and 25% on sales growth. Investors should note the increased impact on fourth-quarter 2004 earnings per share, now estimated at $0.24-$0.27, up from the previous projection of $0.19-$0.24, due to these restructuring charges. The company also announced the election of J. Michael Cook, retired Chairman and CEO of Deloitte & Touche LLP, to its Board of Directors, effective February 1, 2005.
Key Highlights
- 1Eli Lilly revised its estimated pretax charges for restructuring actions upwards to a range of $400 million to $465 million (previously $320 million to $420 million).
- 2The increase in estimated charges is primarily due to asset impairments related to the reconfiguration of the Prince William County, Virginia facility.
- 3The estimated impact on fourth-quarter 2004 earnings per share from asset impairments and restructuring is now expected to be between $0.24 and $0.27 per share (previously $0.19 to $0.24 per share).
- 4Non-cash charges for restructuring are now estimated between $360 million and $390 million, with cash expenditures estimated between $40 million and $75 million.
- 5The company has set the 2005 bonus targets for employees, with 75% of the company performance measure based on earnings-per-share growth and 25% on sales growth.
- 6J. Michael Cook, retired Chairman and CEO of Deloitte & Touche LLP, was elected to the Eli Lilly Board of Directors, effective February 1, 2005, and will serve on the audit and compensation committees.